We work with a broad range of partners, starting with the countries and affected communities who identify challenges and potential solutions, and the researchers and companies creating innovative new products. Through innovative financing solutions like volume guarantees, we lower prices for those products and help get them to market and to those who need them most.
Identify health challenges.
We work with countries, communities and health agencies to identify challenges that are slowing progress towards global health goals.
Find potential solutions.
We work with partners to find promising new health products and solutions.
Invest in innovative products.
We work with implementing partners to address market barriers to get the new product to the people who need it.
We work with countries,
implementing partners and communities to make sure the product works for people in the real world.
Use evidence for policy change.
The WHO uses evidence from our investments to create policy and guidance so that the product can be used more widely.
We partner with donors, countries, communities and health agencies to take the products to scale so people everywhere can benefit.
Unitaid is helping to close a yawning diagnostics gap. Through its partners, Unitaid has invested more than US$ 300 million in a range of projects to widen availability of affordable, quality-assured diagnostic technologies in low- and middle-income countries. One initiative is the OPP-ERA project, which promotes access to Open Polyvalent Platforms (OPPs) – an innovative open laboratory system that enables HIV viral-load testing as well as a host of molecular tests to diagnose tuberculosis and viral hepatitis. The system is flexible, rapid, and easy to use and maintain for trained technicians, with machines suited to health clinics even in remote regions. Innovative technologies such as these ensure that young patients, wherever they happen to live, can quickly get the treatment they need.Learn More